ArticleDocumenta ophthalmologica. Advances in ophthalmology2026
Autosomal dominant Riggs-type congenital stationary night blindness with fundus sheen and retinal atrophy due to a novel GNAT1 p.Gln200Arg variant.
Article in Documenta ophthalmologica. Advances in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo report an Australian family with congenital stationary night blindness (CSNB, OMIM#139,330) harbouring a novel GNAT1 c.599A > G (p.Gln200Arg) variant. In contrast to previous case reports we observed a fundus sheen, outer retinal changes and electrophysiological features of cone dysfunction in addition to a Riggs-type CSNB.
methodsOphthalmic history, clinical examination and multimodal imaging including fundus autofluorescence (FAF) and optical coherence tomography (OCT) were obtained. Full-field electroretinography (ERG) was conducted according to the International Society for Clinical Electrophysiology of Vision (ISCEV) standards. Genetic testing was performed using a targeted next-generation sequencing panel with familial segregation confirmed by Sanger sequencing. In silico prediction tools and protein structural modelling were used to evaluate the pathogenicity and functional impact of the GNAT1 p.Gln200Arg variant respectively.
resultsOur proband, a 21-year-old transgender male, and his 62-year-old mother had a lifelong history of nyctalopia and visual acuity of 6/6 OU. The mother exhibited a golden sheen, sectoral chorioretinal atrophy and bone spicules. In the proband FAF imaging revealed hypoAF inferiorly with an arc of hyperAF whilst his mother had regions of hypoAF associated with outer retinal atrophy. Full-field electroretinography in the proband showed a cone-isolated retina with normal light-adapted responses. The mother had reduced and delayed light-adapted 30 Hz flicker. Both carried the GNAT1 variant NM_000172.4:c.599A > G (p.Gln200Arg). In silico analysis predicted impaired GTPase activity in Arg200 and constitutively active signally after photoactivation. The c.599A > G variant was classified as likely pathogenic.
conclusionsOur study suggests the GNAT1 p.Gln200Arg variant can manifest as both a Riggs-type CSNB and a rod-cone dystrophy within the same pedigree. This work expands the phenotypic spectrum of GNAT1-associated retinopathy and identifies GNAT1 as another potential cause of a fundus sheen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.